- Catalyst Pharmaceuticals (CPRX, Financial) will release its Q1 2025 financial results on May 7, 2025, after market close.
- A conference call and webcast will be held on May 8, 2025, at 8:30 AM ET to discuss these results and provide a company update.
- Investors can access the webcast via the company's website, with a replay available for at least 30 days.
Catalyst Pharmaceuticals, Inc. (CPRX), a commercial-stage biopharmaceutical company that specializes in rare and difficult-to-treat diseases, has announced it will publish its first quarter financial results for 2025 after the market closes on May 7, 2025. The company's management will hold a subsequent conference call and webcast on May 8, 2025, at 8:30 AM ET to discuss the results as well as a business update.
To join the conference call, U.S. and Canadian investors should dial (833) 316-2483, while international participants can dial (785) 838-9284. Interested parties can also access the webcast through the Investors section of Catalyst's website at www.catalystpharma.com, where a replay will be available for at least 30 days post-event.
Catalyst Pharmaceuticals prides itself on delivering life-changing treatments for patients with rare conditions through the development and commercialization of novel medicines. The company, headquartered in Coral Gables, Florida, has received recognition for its growth and success, including being named on the Forbes 2025 list of America's Most Successful Mid-Cap Companies and the 2024 Deloitte Technology Fast 500â„¢ list.
